Shares of Gilead Sciences Inc rose 6per cent on Friday after its antiviral drug, remdesivir, became the first and only approved treatment for COVID-19 in the United States.
Gilead shares rise after United States approves remdesivir as COVID-19 drug
- Advertisement -
Most Popular
Japan leads global long-bond drop as spending takes centre-stage
The UK and France, meanwhile, have seen borrowing costs jump as they struggle to reduce their vast debt piles
Federal Reserve’s Powell asks watchdog to take fresh look at renovation project: Politico
US Federal Reserve Chair Jerome Powell has asked the Fed board’s inspector general to take a fresh look at the project...
Stablecoin has long road to mainstream payments, Mastercard says
The pending regulatory clarity has drawn new entrants into the digital asset sector and encouraged financial institutions to consider their place in...
